379 related articles for article (PubMed ID: 15261576)
1. Protein microarray detection strategies: focus on direct detection technologies.
Espina V; Woodhouse EC; Wulfkuhle J; Asmussen HD; Petricoin EF; Liotta LA
J Immunol Methods; 2004 Jul; 290(1-2):121-33. PubMed ID: 15261576
[TBL] [Abstract][Full Text] [Related]
2. [Application of quantitative proteomic analysis for cancer therapy using "reverse-phase" protein lysate microarrays].
Nishizuka S; Spurrier B; Honkanen P; Austin J; Wakabayashi G
Gan To Kagaku Ryoho; 2008 Feb; 35(2):200-5. PubMed ID: 18281757
[TBL] [Abstract][Full Text] [Related]
3. Pegylated, steptavidin-conjugated quantum dots are effective detection elements for reverse-phase protein microarrays.
Geho D; Lahar N; Gurnani P; Huebschman M; Herrmann P; Espina V; Shi A; Wulfkuhle J; Garner H; Petricoin E; Liotta LA; Rosenblatt KP
Bioconjug Chem; 2005; 16(3):559-66. PubMed ID: 15898722
[TBL] [Abstract][Full Text] [Related]
4. Protein biochips: A new and versatile platform technology for molecular medicine.
Lueking A; Cahill DJ; Müllner S
Drug Discov Today; 2005 Jun; 10(11):789-94. PubMed ID: 15922937
[TBL] [Abstract][Full Text] [Related]
5. Antibody-based proteomics: analysis of signaling networks using reverse protein arrays.
Voshol H; Ehrat M; Traenkle J; Bertrand E; van Oostrum J
FEBS J; 2009 Dec; 276(23):6871-9. PubMed ID: 19860827
[TBL] [Abstract][Full Text] [Related]
6. Protein-protein interaction studies on protein arrays: effect of detection strategies on signal-to-background ratios.
Hurst R; Hook B; Slater MR; Hartnett J; Storts DR; Nath N
Anal Biochem; 2009 Sep; 392(1):45-53. PubMed ID: 19464993
[TBL] [Abstract][Full Text] [Related]
7. Protein and lysate array technologies in cancer research.
Spurrier B; Honkanen P; Holway A; Kumamoto K; Terashima M; Takenoshita S; Wakabayashi G; Austin J; Nishizuka S
Biotechnol Adv; 2008; 26(4):361-9. PubMed ID: 18514460
[TBL] [Abstract][Full Text] [Related]
8. Protein microarrays and novel detection platforms.
Chandra H; Reddy PJ; Srivastava S
Expert Rev Proteomics; 2011 Feb; 8(1):61-79. PubMed ID: 21329428
[TBL] [Abstract][Full Text] [Related]
9. Protein and small molecule microarrays: powerful tools for high-throughput proteomics.
Uttamchandani M; Wang J; Yao SQ
Mol Biosyst; 2006 Jan; 2(1):58-68. PubMed ID: 16880923
[TBL] [Abstract][Full Text] [Related]
10. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy.
Calvo KR; Liotta LA; Petricoin EF
Biosci Rep; 2005; 25(1-2):107-25. PubMed ID: 16222423
[TBL] [Abstract][Full Text] [Related]
11. Human protein atlas and the use of microarray technologies.
Hober S; Uhlén M
Curr Opin Biotechnol; 2008 Feb; 19(1):30-5. PubMed ID: 18187316
[TBL] [Abstract][Full Text] [Related]
12. Label-free detection methods for protein microarrays.
Yu X; Xu D; Cheng Q
Proteomics; 2006 Oct; 6(20):5493-503. PubMed ID: 16991201
[TBL] [Abstract][Full Text] [Related]
13. Reverse-phase protein microarrays: application to biomarker discovery and translational medicine.
VanMeter A; Signore M; Pierobon M; Espina V; Liotta LA; Petricoin EF
Expert Rev Mol Diagn; 2007 Sep; 7(5):625-33. PubMed ID: 17892368
[TBL] [Abstract][Full Text] [Related]
14. A cancer protein microarray platform using antibody fragments and its clinical applications.
Song S; Li B; Wang L; Wu H; Hu J; Li M; Fan C
Mol Biosyst; 2007 Feb; 3(2):151-8. PubMed ID: 17245494
[TBL] [Abstract][Full Text] [Related]
15. Technology insight: pharmacoproteomics for cancer--promises of patient-tailored medicine using protein microarrays.
Wulfkuhle JD; Edmiston KH; Liotta LA; Petricoin EF
Nat Clin Pract Oncol; 2006 May; 3(5):256-68. PubMed ID: 16683004
[TBL] [Abstract][Full Text] [Related]
16. Protein-detecting microarrays: current accomplishments and requirements.
Tomizaki KY; Usui K; Mihara H
Chembiochem; 2005 May; 6(5):782-99. PubMed ID: 15791688
[TBL] [Abstract][Full Text] [Related]
17. Microplate-based, label-free detection of biomolecular interactions: applications in proteomics.
Cunningham BT; Laing L
Expert Rev Proteomics; 2006 Jun; 3(3):271-81. PubMed ID: 16771700
[TBL] [Abstract][Full Text] [Related]
18. Reverse phase protein microarrays for theranostics and patient-tailored therapy.
Espina V; Wulfkuhle J; Calvert VS; Liotta LA; Petricoin EF
Methods Mol Biol; 2008; 441():113-28. PubMed ID: 18370315
[TBL] [Abstract][Full Text] [Related]
19. Tissue microarrays: fast-tracking protein expression at the cellular level.
Warford A
Expert Rev Proteomics; 2004 Oct; 1(3):283-92. PubMed ID: 15966825
[TBL] [Abstract][Full Text] [Related]
20. Reverse-phase protein microarrays.
Pierobon M; Vanmeter AJ; Moroni N; Galdi F; Petricoin EF
Methods Mol Biol; 2012; 823():215-35. PubMed ID: 22081348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
